We additionally treated mice with PD-L1 blocking antibodies and found that PD-L1 blockade combined with ablation of Afap1l2 in T cells synergistically reduced tumor growth and significantly increased the survival of mice (Figures 6H and 6I). This evidence concerns the gene AFAP1L2 and neoplasm.